Akero Therapeutics (AKRO) Tops Q2 EPS by 2c

Akero Therapeutics (NASDAQ: AKRO) reported Q2 EPS of ($0.81), $0.02 better than the analyst estimate of ($0.83).

For earnings history and earnings-related data on Akero Therapeutics (AKRO) click here.

You May Also Be Interested In

• Comcast (CMCSA) Falls Following Comments at Goldman Sachs Conf, Down 4%
• Opus Genetics (IRD) PT Raised to $17 at Citizens
• Academy Sports surges on earnings beat and raised guidance